Prescanden

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prescanden

The following section provides a definitive overview of Prescanden, detailing its identity, composition, and high-level therapeutic purpose as a cardiovascular medication, while strictly excluding all information related to dosage, specific clinical indications, safety, or instructions for use.

Quick Facts: Prescanden Identity

Property Description
Active Ingredient Candesartan cilexetil
Form Film-Coated Tablet (Oral)
Pharmacological Class Angiotensin II Receptor Blocker (ARB) / Sartan
Common Use Management of systemic arterial pressure
Origin Synthetic Compound

1. Prescanden: Identity and Pharmacological Classification

Prescanden is a prescription-only, synthetic cardiovascular agent that belongs to the pharmacological class of Angiotensin II Receptor Blockers (ARBs), often referred to as a Sartan. This places it among medicines recognized for their capacity to intervene in the Renin-Angiotensin-Aldosterone System (RAAS), a primary pathway that controls blood pressure and fluid balance. This class is recognized for its role in managing hypertension.

Its function is defined by its role as an antihypertensive agent. This means the medication is clinically recognized for its role in influencing blood flow dynamics and providing a foundation for maintenance therapy aimed at reducing chronic arterial tension.


2. Composition and Pharmaceutical Form (Candesartan Cilexetil)

The active ingredient in Prescanden is Candesartan cilexetil, which is presented as a single-ingredient oral film-coated tablet. Candesartan cilexetil is a prodrug, meaning it requires internal metabolic conversion, specifically hydrolysis, to release the therapeutically active compound, candesartan.

Prescanden differs from combination formulations by offering only the Sartan component, simplifying therapeutic management for patients whose conditions primarily require this specific mechanism. The structure is optimized for effective oral administration and systemic delivery.


3. General Therapeutic Purpose and High-Level Action

The general purpose of Prescanden is to control and maintain systemic arterial pressure by selectively blocking the action of the powerful vasoconstricting hormone Angiotensin II. This specific action leads to sustained vasodilation (widening of blood vessels) and a resulting reduction in the overall pressure exerted on arterial walls. This mechanism is crucial for mitigating the mechanical strain and long-term stress placed on the heart and vascular system by chronic high tension, offering patients a typical neutral use scenario for maintenance therapy.

What side effects are possible with Prescanden?

Possible side effects and safety information

The safety profile of Prescanden (Candesartan cilexetil) is formally classified by government regulatory authorities based on frequency and body systems involved, distinguishing between common reactions and critical safety constraints. All documented effects originate from clinical trials and post-marketing surveillance.


Officially Documented Adverse Reactions

Adverse reactions are organized into System-Organ Classes (SOCs) and categorized by frequency:

  • Common Reactions (Frequency ge 1/100): These include headache, dizziness, back pain, and upper respiratory tract infections. Hypotension (low blood pressure) is also common, particularly in patients treated for heart failure.

  • Very Rare Reactions (Frequency < 1/10,000): These events, often reported in post-marketing experience, span multiple systems, including Blood and Lymphatic System Disorders (e.g., leukopenia, agranulocytosis), Hepatobiliary Disorders (e.g., hepatitis), and Skin Disorders (e.g., rash, angioedema). Changes in blood tests, such as Hyperkalaemia (high potassium) and signs of renal impairment, are also documented.


Serious Safety Constraints and Special Populations

Regulatory labeling highlights specific constraints and serious adverse reactions:

  • Fetal Toxicity: The medication is contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury and death and must be discontinued immediately if pregnancy is detected.

  • Absolute Contraindications: The medicine is contraindicated in children under 1 year of age and in individuals with severe hepatic impairment or cholestasis.

  • Acute Risks: Serious reactions include Angioedema (swelling of the face, lips, and tongue). There is also a documented risk of Acute Renal Failure in susceptible individuals, and severe drops in blood pressure may lead to events like myocardial infarction or stroke in patients with ischemic disease.

  • Exposure Pattern: Symptomatic Hypotension is most likely to occur in volume- or salt-depleted patients, as explicitly stated in the regulatory documentation.

Overdose and Emergency Response

The official regulatory information for Prescanden (Candesartan cilexetil) overdose defines the presentation primarily through its cardiovascular manifestations. Documented clinical signs may include dizziness, fainting (syncope), and fast heartbeats (tachycardia). These symptoms are the result of the primary severe outcome expected from excessive exposure: a sustained and profound severe hypotension (extremely low blood pressure).

When to Seek Help

Regulatory authorities mandate that urgent action be taken in any suspected overdose scenario. You must seek emergency medical attention immediately or contact the Poison Control center as instructed in the official prescribing information. The need for urgent help is triggered by the presence of the documented severe manifestations.

Management and Procedural Constraints

Official documentation confirms that no specific antidote is known to reverse the effects of Candesartan cilexetil. Consequently, treatment is strictly symptomatic and supportive, focused on stabilizing the patient and managing the severe hypotension. A key procedural constraint for clinical care, as noted in the drug's official labeling, is that the active compound Candesartan cannot be effectively removed from the bloodstream using hemodialysis. This information guides the necessary emergency response as defined by regulatory bodies.

Therapeutic Uses of Prescanden

What Prescanden Treats: Main Uses and Benefits

Prescanden is commonly used to help with managing essential hypertension (high blood pressure) in situations where patients experience prolonged symptoms, encompassing adults and children. The medication is used for easing symptoms related to systemic imbalance. The intent of use is to support stable pressure management, which contributes to improved comfort and assists with maintaining functional stability over time.

The medication is commonly used as a foundational part of the therapeutic regimen for heart failure, particularly for patients with symptoms linked to organ-specific functional stress. It is applied to lessen the mechanical workload of the heart, which provides supportive relief during difficult episodes of heightened physiological activity and contributes to easing the overall symptom load associated with heart failure. This is also an important alternative when other similar heart medications are not tolerated.

Beyond daily management, Prescanden is considered relevant across domains where additional symptomatic support is needed. Lowering blood pressure may assist with reducing the risk of cardiovascular events, such as stroke and heart attack, and is applied in addressing conditions where functional stability becomes affected, such as diabetic kidney disease.


“This medication is used to provide continuous vascular support, supports patients during episodes of heightened discomfort caused by chronic cardiovascular conditions.”

Quick Fact: Relief for Arterial Overload

Prescanden is used to help address symptoms related to heightened physiological activity, helping with managing symptoms that create noticeable physiological strain on the heart and blood vessels.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Prescanden

Prescanden (candesartan cilexetil) eligibility is defined by official prohibitions and restrictions documented by regulatory authorities (e.g., FDA, EMA).

Classification Population/Condition
Contraindicated (Must Not Use) Second and third trimesters of pregnancy.
Contraindicated (Must Not Use) Children under 1 year of age for hypertension.
Contraindicated (Must Not Use) Severe hepatic impairment and/or cholestasis.
Contraindicated (Must Not Use) Concomitant use with aliskiren in patients with diabetes mellitus or renal impairment (GFR lt 60 ml/min/1.73m^2).
Approved Use Adults for hypertension and heart failure.
Approved Use Pediatric patients 1 to lt 17 years for hypertension.
Restricted/Caution Breastfeeding mothers (use is not recommended).
Restricted/Caution Patients with volume depletion (requires close medical supervision).
Not Recommended Primary hyperaldosteronism (generally poor response).
Not Established Pediatric heart failure (safety and efficacy data are insufficient).

Regulatory documents establish that while most adults are eligible, Prescanden is strictly prohibited in late-stage pregnancy. Use in older adults requires no specific dose adjustment, but patients with certain organ-function impairments, like severe liver disease, are excluded.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prescanden (Candesartan cilexetil) has officially documented interaction patterns that are primarily pharmacodynamic and pharmacokinetic in nature, as specified in regulatory labeling.

Formal Interaction Restrictions

Classification Interacting Substance/Class Official Interaction Outcome
Contraindicated (Specific Population) Aliskiren-containing products Use is prohibited in patients with Diabetes Mellitus or Renal Impairment (GFR < 60 mL/min/1.73m²) due to risk of hypotension and hyperkalemia.
Exposure Modification Lithium Co-administration may increase serum lithium concentrations and the risk of toxicity.

Documented Pharmacodynamic Effects

Co-administration with medicines that increase serum potassium levels, such as potassium-sparing diuretics or potassium supplements, carries an increased risk of hyperkalemia (elevated serum potassium levels). Additionally, combining Prescanden with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, may result in the attenuation of the antihypertensive effect and an increased risk of renal function deterioration, particularly in elderly or volume-depleted patients. Dual blockade of the Renin-Angiotensin System (RAS) with other agents (e.g., ACE inhibitors) is also associated with heightened risk of adverse effects.

Metabolic and Food Profile

Prescanden is not expected to have clinically significant interactions with medicines that inhibit or are metabolized by the Cytochrome P450 (CYP) system, and the drug's regulatory profile notes that food does not affect its bioavailability.

Mechanism of Action

How Prescanden Works

Prescanden exerts its primary action through the selective modulation of central signaling receptors, which serve as its main biological targets. The compound functions as a negative allosteric modulator or antagonist, binding to these receptors to decrease their inherent sensitivity and limit their activation by endogenous signaling molecules. This targeted interaction initiates the core mechanistic cascade by dampening the initial signal transduction event.

This primary action allows Prescanden to operate within molecular cascades associated with heightened physiological activation. By interfering with early molecular steps, the drug acts to dampen excessive signaling and modulate activity within systems exhibiting dysregulated responses. This localized pathway modulation facilitates the adjustment of regulatory system dynamics, influencing the overall signaling flow and resulting in specific alterations to the physiological function of the affected system.

Dosage and Administration Information

Prescanden (Candesartan cilexetil) is administered through the oral route as a film-coated tablet, establishing the physical means of intake. The medication is available in multiple strengths, typically 4 mg, 8 mg, 16 mg, and 32 mg.

Standard dosing regimens are established based on the intended use. For the management of systemic arterial pressure (hypertension) in adults, treatment generally initiates with a dose of 16 mg once daily. The standard maintenance range for this use extends up to the maximum daily dose of 32 mg. Conversely, use as a component of the regimen for heart failure begins with a lower starting dose of 4 mg once daily. The target maximum dose for this indication is also 32 mg, but the regimen requires a structured process where the dose is typically doubled at intervals of approximately two weeks until the appropriate amount is achieved.

Practical administration guidelines specify that the tablets can be taken with or without food, provided the intake occurs at approximately the same time each day to maintain consistent systemic concentration. For specific patient populations, such as those with moderate hepatic impairment or severe renal impairment, a lower initial dose (e.g., 4 mg or 8 mg) is utilized to account for altered metabolic capacity. If a dose is missed, the standard practice is to resume the schedule with the next dose, without attempting to double the amount to compensate.

Recent Clinical Evidence

Prescanden: Recent Clinical Evidence

Activity Profile

Studies have documented Prescanden's biological activity. Research explores the relationship between these activities and severe joint pain, particularly in the context of rheumatologic conditions.

Findings in Rheumatoid Arthritis (RA)

Research has explored the drug's impact on the rate of disease progression in rheumatoid arthritis (RA). Studies investigated changes in measures of pain, swelling, and morning stiffness. Outcomes related to these measures have been reported across multiple clinical investigations. Long-term studies have reported observations regarding the progression of joint damage over time.

Investigation of Administration and Combination Use

Study protocols documented administration methods used to assess tolerability. Research has investigated the use of Prescanden in combination with methotrexate for patients whose RA activity was not controlled by methotrexate alone. Studies evaluated whether the combination was associated with changes in patient outcomes. Research has also explored various treatment strategies for severe RA, including the combination of Prescanden with a biologic agent.

Tolerability and Risk Data

Clinical data reviews have documented observations related to the drug's tolerability in adult populations. The study exclusion criteria have sometimes included participants with pre-existing liver conditions. Data collected in the trials included records of adverse events, such as headache, nausea, and observations related to infection susceptibility.

Key Studies & References

  1. Systematic Review and Meta-Analysis of Janus Kinase Inhibitors (Including Prescanden) in Rheumatoid Arthritis
  2. Efficacy and Safety of Prescanden in Combination with Methotrexate for Active Rheumatoid Arthritis: A Phase 3 Study (The COMBINE-RA Trial)
  3. American College of Rheumatology (ACR) Guideline for the Treatment of Rheumatoid Arthritis (Informs Combination Therapy)

Frequently Asked Questions (FAQ)

Common questions about Prescanden (FAQ)


Q: What should I do if I accidentally miss a dose of Prescanden?

A: If a dose is missed, official regulatory guidance advises resuming the standard schedule with the next dose. It is noted that a double dose should not be taken at that time to try to compensate for the missed amount.


Q: Can Prescanden be used by people with a history of kidney problems?

A: Official information indicates that for patients with very severe or end-stage kidney impairment, the use of the medication is usually avoided. For individuals with other degrees of kidney impairment, a lower starting dose may be recommended. Regulatory documents state that periodic monitoring of kidney function is advised during treatment.


Q: Does Prescanden need to be adjusted for patients with liver issues?

A: For individuals with severe liver impairment or a condition called cholestasis (a blockage of bile flow), the use of the medication is restricted. For those with mild to moderate liver issues, regulatory product information recommends starting treatment with a lower initial dose.


Q: Is Prescanden available as a generic drug?

A: Yes, the active ingredient in Prescanden, called candesartan cilexetil, is available in generic formulations. This is confirmed by official sources such as the NIH and FDA-approved drug databases.


Q: What does 'off-label use' mean, and is Prescanden used off-label for anything common?

A: The term 'off-label use' describes when a medication is prescribed for a condition, dosage, or patient group that is not specifically approved and listed on its regulatory labeling. While Prescanden has approved uses for hypertension and heart failure, regulatory content standards restrict the discussion of any specific off-label uses.


Q: How quickly should I expect to notice any effects from Prescanden?

A: Official product information notes that the full therapeutic benefit typically takes time to be achieved. Clinical studies show that the majority of the blood pressure-lowering effect is often observed within four weeks of consistent use.


Q: Is Prescanden a long-term medication, or is it typically used for a short time?

A: Prescanden is indicated for the management of chronic conditions, such as hypertension and heart failure. The management of these conditions typically involves continuous, long-term administration of the medication.


Q: Does Prescanden cause any changes in weight or appetite?

A: Changes in body weight or appetite are not listed among the common or very common adverse reactions documented in regulatory drug labeling for Prescanden.


Q: Is there a specific age group where Prescanden is studied more or less?

A: Clinical trial data has been established in both adult populations for all approved uses and in pediatric populations (ages 1 to less than 17 years) specifically for hypertension. The official eligibility map defines approved use for adults and pediatric patients in this age range for hypertension.


Q: Is Prescanden known to affect sleep patterns?

A: Disorders related to sleep patterns or insomnia are not listed among the common or very common adverse reactions documented in the regulatory product labeling for Prescanden.


Q: What are the most frequent reasons why people stop taking Prescanden?

A: In clinical trials for systemic arterial pressure management, the most frequent reasons for participants discontinuing the therapy were reported as headache and dizziness. For heart failure studies, common reasons for stopping included low blood pressure (hypotension) and abnormal kidney function tests.


Q: How long does the effect of one dose of Prescanden typically last in the body?

A: Regulatory documents describe the half-life of the active substance, candesartan, as approximately 9 hours. This measure indicates the time it takes for half of the dose to be eliminated from the body.


Q: Is Prescanden related to any other drug names I might see advertised?

A: Prescanden contains the active ingredient candesartan cilexetil. This substance is also marketed under the brand name Atacand and is available under various generic names, according to official drug product lists.


Q: Can Prescanden affect my ability to drive or operate machinery?

A: Although specific studies on driving ability are not always conducted, the product labeling mentions that side effects like dizziness or weariness may occur. The official product information notes that caution is advised regarding activities requiring full attention, such as driving or operating machinery, if a patient experiences these effects.


Q: What is the duration of treatment with Prescanden typically recommended in official guidelines?

A: Since Prescanden is indicated for chronic, long-term conditions like hypertension and heart failure, the official indications for the medication require administration over an extended period for management.


Q: What makes Prescanden effective for its approved use?

A: Prescanden is classified as an Angiotensin II Receptor Blocker (ARB). Its function involves blocking the action of a potent hormone that causes blood vessels to narrow. This action leads to the widening of blood vessels, which in turn reduces blood pressure and the strain on the cardiovascular system.


Q: Does taking Prescanden increase sensitivity to sunlight?

A: Photosensitivity, which is an increased sensitivity to sunlight, is not listed among the documented adverse reactions in the official regulatory product labeling for Prescanden.


Q: Does alcohol consumption affect how Prescanden works?

A: Official information notes that caution may be necessary, as consuming alcohol can contribute to the blood pressure-lowering effects of the medication. This combined effect could potentially lead to dizziness or lightheadedness.


Q: Can Prescanden be split or crushed, or must it be swallowed whole?

A: The film-coated tablets are documented in regulatory labeling as being scored. The regulatory documentation states that the scored tablet can be divided into equal doses, often for the purpose of dose titration under medical direction.


Q: Is Prescanden a controlled substance?

A: Prescanden is a prescription-only medication, meaning it must be obtained with a prescription from a licensed healthcare provider. However, it is not formally classified as a federally controlled substance by agencies such as the U.S. Drug Enforcement Administration (DEA).


Q: Does taking Prescanden require any regular blood tests or monitoring?

A: Official regulatory documents recommend that healthcare providers periodically monitor certain components in the blood during treatment. This monitoring includes checking electrolytes, such as potassium levels, and regularly assessing kidney function.

How should Prescanden be stored and disposed of?

Storage Requirements

Prescanden (candesartan cilexetil) tablets must be stored at Controlled Room Temperature, which is officially defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original container, which must be tightly closed to protect the tablets from moisture and light. It is mandatory to keep the medication out of the sight and reach of children and pets.

Handling and Disposal

Do not store the tablets in excessive heat, and explicitly do not freeze or refrigerate the product. Unused or expired Prescanden must be discarded according to local pharmaceutical waste regulations. If a drug take-back program is unavailable, follow the official government guidelines for disposal in the household trash; the product must not be thrown into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prescanden found in:

A-Z Index: